Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017

Matthew Eckler Initiated (ABEO) at Buy and Held Target at $575 on, Sep 15th, 2017

Matthew Eckler of RBC Capital, Initiated "Abeona Therapeutics Inc." (ABEO) at Buy and Held Target at $575 on, Sep 15th, 2017.

Matthew, nor any peers, have made any analyst calls on ABEO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30